Corrigendum: Revisiting the safety of aspartame" by Arbind Kumar Choudhary and Etheresia Pretorius (Nutrition Reviews (2017) 75 (718-730) DOI: 10.1093/nutrit/nux035);Revisiting the safety of aspartame

Nutrition Reviews

Volumn 75, Issue 9, 2017, Pages 718-730

  Choudhary, Arbind Kumar ^a   Pretorius, Etheresia ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Aspartame; Aspartic acid; Methanol; Phenylalanine

Indexed keywords

ACETYLCHOLINESTERASE; ANTIOXIDANT; ASPARTAME; ASPARTIC ACID; DIPEPTIDE; FIBRIN; FORMALDEHYDE; FREE RADICAL; GLUCOSE; INSULIN; METHANOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONNUTRITIVE SWEETENER; OXIDIZING AGENT; PHENYLALANINE; SEROTONIN; SWEETENING AGENT;

ARTICLE; BEVERAGE; BLOOD CELL; BODY WEIGHT; BRAIN; CELL MEMBRANE; CHEMICAL STRUCTURE; DIETARY INTAKE; DOSE RESPONSE; ENDOCRINE GLAND; ERYTHROCYTE MEMBRANE; FOOD ANALYSIS; FOOD AND DRUG ADMINISTRATION; FOOD SAFETY; FRUIT JUICE; GENITAL SYSTEM; GLUCOSE TOLERANCE; HEART; HUMAN; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN TOLERANCE TEST; INTESTINE FLORA; KIDNEY; LIVER; LUNG; METABOLITE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS; TOXICOKINETICS; ANALYSIS; ANIMAL; CARBONATED BEVERAGE; DISEASE MODEL; DRUG EFFECTS; METABOLISM; OBSERVATIONAL STUDY;

ANIMALS; ASPARTAME; BLOOD CELLS; BRAIN; CARBONATED BEVERAGES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN; FOOD SAFETY; GASTROINTESTINAL MICROBIOME; HEART; HUMANS; IMMUNE SYSTEM; KIDNEY; LIVER; NON-NUTRITIVE SWEETENERS; OBSERVATIONAL STUDIES AS TOPIC;

EID: 85029572400     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/NUTRIT/NUY041     Document Type: Erratum

References (132)

1. Figlewicz D, Ioannou G, Jay JB, et al. Effect of moderate intake of sweeteners on metabolic health in the rat. Physiol Behav. 2009;98:618-624
2. Mazur RH, Schlatter JM, Goldkamp AH. Structure-taste relationships of some dipeptides. J Am Chem Soc. 1969;91:2684-2691
3. Marinovich M, Galli CL, Bosetti C, et al. Aspartame, low-calorie sweeteners and disease: regulatory safety and epidemiological issues. Food Chem Toxicol. 2013;60:109-115
4. Nofre C, Tinti J-M. Neotame: discovery, properties, utility. Food Chem. 2000;69:245-257
5. Rangan C, Barceloux DG. Food additives and sensitivities. Dis Mon. 2009;55:292-311
6. Rencüzoğullari E, Tüylü BA, Topaktaş M, et al. Genotoxicity of aspartame. Drug Chem Toxicol. 2004;27:257-268
7. Alleva R, Borghi B, Santarelli L, et al. In vitro effect of aspartame in angiogenesis induction. Toxicol in Vitro. 2011;25:286-293
8. Duggett A. Medications that contain aspartame. Drugsdb.com website. http://www.drugsdb.com/cib/aspartame/medications-that-contain-aspartame/. Published June 11, 2012. Accessed January 5, 2017
9. Drug products containing phenylalanine. National PKU News website. https://pkunews.org/drug-products-containing-phenylalanine/. Updated 2007. Accessed January 5, 2017
10. Butchko HH, Stargel WW. Aspartame: scientific evaluation in the postmarketing period. Regul Toxicol Pharmacol. 2001;34:221-233
11. Roberts HJ. Aspartame disease: an FDA-approved epidemic. http://articles.mer cola.com/sites/articles/archive/2004/01/07/aspartame-disease-part-two.aspx. Published January 7, 2004. Accessed July 24, 2017
12. Choudhary AK, Devi RS. Imbalance of the oxidant-antioxidant status by aspartame in the organs of immune system of Wistar albino rats. Afr J Pharm Pharmacol. 2014;8:220-230
13. Ashok I, Sheeladevi R. Neurobehavioral changes and activation of neurodegenerative apoptosis on long-term consumption of aspartame in the rat brain. J Nutr Intermed Metabol. 2015;2:76-85
14. Nakanishi K, Kamikubo T, Matsuno R. Continuous synthesis of N-(benzyloxycarbonyl)-L-aspartyl-L-phenylalanine methyl ester with immobilized thermolysin in an organic solvent. Nat Biotechnol. 1985;3:459-464
15. Bell LN, Labuza TP. Aspartame degradation kinetics as affected by pH in intermediate and low moisture food systems. J Food Sci. 1991;56:17-20
16. Sun J-P, Han Q, Zhang X-Q, et al. Investigations on the degradation of aspartame using high-performance liquid chromatography/tandem mass spectrometry. Chin Chem Lett. 2014;25:1259-1264
17. Chattopadhyay S, Raychaudhuri U, Chakraborty R. Artificial sweeteners-a review. J Food Sci Technol. 2014;51:611-621
18. Quinlan M, Mialon V, Everitt M. Effect of storage on the flavours of cola drinks sweetened with different sweetener systems. In: Corti, ed: Low-Calorie Sweeteners: Present and Future. Basel, Switzerland: Karger Publishers; 1999:58-63
19. Wetzel CR, Bell LN. Chemical stability of encapsulated aspartame in cakes without added sugar. Food Chem. 1998;63:33-37
20. Kroger M, Meister K, Kava R. Low-calorie sweeteners and other sugar substitutes: a review of the safety issues. Compr Rev Food Sci Food Saf. 2006;5:35-47
21. Paixão JA, Rodrigues JB, Esmerino EA, et al. Influence of temperature and fat content on ideal sucrose concentration, sweetening power, and sweetness equivalence of different sweeteners in chocolate milk beverage. J Dairy Sci. 2014;97:7344-7353
22. Singh M, Kumar A, Tarannum N. Water-compatible 'aspartame'-imprinted polymer grafted on silica surface for selective recognition in aqueous solution. Anal Bioanal Chem. 2013;405:4245-4252
23. Daubner SC, Melendez J, Fitzpatrick PF. Reversing the substrate specificities of phenylalanine and tyrosine hydroxylase: aspartate 425 of tyrosine hydroxylase is essential for L-DOPA formation. Biochemistry. 2000;39:9652-9661
24. Choi TB, Pardridge WM. Phenylalanine transport at the human blood-brain barrier. Studies with isolated human brain capillaries. J Biol Chem. 1986;261:6536-6541
25. Weglage J, Wiedermann D, Denecke J, et al. Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria. Ann Neurol. 2001;50:463-467
26. Humphries P, Pretorius E, Naude H. Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr. 2008;62:451-462
27. McBain C, Mayer M. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev. 1994;74:723-760
28. Oppermann JA. Aspartame metabolism in animals. In: Stegink LD, Filer Jr LJ, eds. Aspartame: Physiology and Biochemistry. New York, NY: Marcel Dekker. 1984:141-159
29. Cederbaum AI. Alcohol metabolism. Clin Liver Dis. 2012;16:667-685
30. Hansen JM, Contreras KM, Harris C. Methanol, formaldehyde, and sodium formate exposure in rat and mouse conceptuses: a potential role of the visceral yolk sac in embryotoxicity. Birth Defects Res A Clin Mol Teratol. 2005;73:72-82
31. Barceloux D, Bond G, Krenzelok E, et al. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415-446
32. Johlin FC, Fortman CS, Nghiem D, et al. Studies on the role of folic acid and folate-dependent enzymes in human methanol poisoning. Mol Pharmacol. 1987;31:557-561
33. Magnuson B, Burdock G, Doull J, et al. Aspartame: a safety evaluation based on current use levels, regulations, and toxicological and epidemiological studies. Crit Rev Toxicol. 2007;37:629-727
34. Butchko HH, Stargel WW, Comer CP, et al. Aspartame: review of safety. Regul Toxicol Pharmacol. 2002;35(2 pt 2):S1-S93
35. Soffritti M, Padovani M, Tibaldi E, et al. The carcinogenic effects of aspartame: the urgent need for regulatory re-evaluation. Am J Ind Med. 2014;57:383-397
36. Yilmaz S, Uçar A. A review of the genotoxic and carcinogenic effects of aspartame: does it safe or not? Cytotechnology. 2014;66:875-881
37. Goerss AL, Wagner GC, Hill WL. Acute effects of aspartame on aggression and neurochemistry of rats. Life Sci. 2000;67:1325-1329
38. Dailey J, Lasley S, Burger R, et al. Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame. Epilepsy Res. 1991;8:122-133
39. Stegink LD, Filer L, Bell EF, et al. Repeated ingestion of aspartame-sweetened beverages: further observations in individuals heterozygous for phenylketonuria. Metabolism. 1990;39:1076-1081
40. USDA Nutrient Data Laboratory, Food and Nutrition Information Center, and Information Systems Division of the National Agricultural Library. USDA Food Compostion Databases. https://ndb.nal.usda.gov/ndb/. Revised May 2016. Accessed July 17, 2017
41. Butchko HH, Kotsonis FN. Acceptable daily intake vs actual intake: the aspartame example. J Am Coll Nutr. 1991;10:258-266
42. Ernstgård L, Shibata E, Johanson G. Uptake and disposition of inhaled methanol vapor in humans. Toxicol Sci. 2005;88:30-38
43. Hou C-Y, Lin Y-S, Wang YT, et al. Effect of storage conditions on methanol content of fruit and vegetable juices. J Food Compost Anal. 2008;21:410-415
44. Dorokhov YL, Shindyapina AV, Sheshukova EV, et al. Metabolic methanol: molecular pathways and physiological roles. Physiol Rev. 2015;95:603-644
45. Davoli E, Cappellini L, Airoldi L, et al. Serum methanol concentrations in rats and in men after a single dose of aspartame. Food Chem Toxicol. 1986;24:187-189
46. Španěl P, Dryahina K, Vicherková P, et al. Increase of methanol in exhaled breath quantified by SIFT-MS following aspartame ingestion. J Breath Res. 2015;9:047104. doi:10.1088/1752-7155/9/4/047104
47. Renwick A, Nordmann H. First European conference on aspartame: putting safety and benefits into perspective. Synopsis of presentations and conclusions. Food Chem Toxicol. 2007;45:1308-1313
48. Di Pasquale M. Use of nutritive and nonnutritive sweeteners. J Am Diet Assoc. 1998;98:580-587
49. US Food and Drug Administration. Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, MD: US Food and Drug Administration, Center for Drug Evaluation and Research; https://www.fda.gov/downloads/drugs/guidan ces/ucm078932.pdf. Published July 2005. Accessed July 24, 2017
50. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22:659-661
51. Fernstrom JD. Oral aspartame and plasma phenylalanine: pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine. J Neural Transm. 1989;75:159-164
52. Wurtman RJ, Maher TJ. Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents. J Neural Transm. 1987;70:169-173
53. Kotsonis FN, Hjelle JJ. The safety assessment of aspartame: scientific and regulatory considerations. In: Tschanz C, Butchko HH, Stargel WW, Kotsonis FN, eds. The Clinical Evaluation of a Food Additive: Assessment of Aspartame. Boca Raton, FL: CRC Press; 1996:23-41
54. Reynolds W, Stegink LD, Filer L, et al. Aspartame administration to the infant monkey: hypothalamic morphology and plasma amino acid levels. Anat Rec (Hoboken). 1980;198:73-85
55. Tsakiris S, Giannoulia-Karantana A, Simintzi I, et al. The effect of aspartame metabolites on human erythrocyte membrane acetylcholinesterase activity. Pharmacol Res. 2006;53:1-5
56. Simintzi I, Schulpis KH, Angelogianni P, et al. The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats. Pharmacol Res. 2007;56:155-159
57. Simintzi I, Schulpis KH, Angelogianni P, et al. The effect of aspartame metabolites on the suckling rat frontal cortex acetylcholinesterase. An in vitro study. Food Chem Toxicol. 2007;45:2397-2401
58. Ashok I, Sheeladevi R, Wankhar D. Long term effect of aspartame (artificial sweetener) on membrane homeostatic imbalance and histopathology in the rat brain. Free Radicals and Antioxidants. 2013;3:S42-S49
59. Ashok I, Sheeladevi R, Wankhar D. Effect of long-term aspartame (artificial sweetener) on anxiety, locomotor activity and emotionality behavior in Wistar albino rats. Biomedicine and Preventive Nutrition. 2014;4:39-43
60. Iyyaswamy A, Rathinasamy S. Effect of chronic exposure to aspartame on oxidative stress in the brain of albino rats. J Biosci. 2012;37:679-688
61. Villareal LMA, Cruz RAM, Ples MB, et al. Neurotropic effects of aspartame, stevia and sucralose on memory retention and on the histology of the hippocampus of the ICR mice (Mus musculus). Asian Pac J Trop Biomed. 2016;6:114-118
62. Bergstrom BP, Cummings DR, Skaggs TA. Aspartame decreases evoked extracellular dopamine levels in the rat brain: an in vivo voltammetry study. Neuropharmacology. 2007;53:967-974
63. Vences-Mejía A, Labra-Ruíz N, Hernández-Martínez N, et al. The effect of aspartame on rat brain xenobiotic-metabolizing enzymes. Hum Exp Toxicol. 2006;25:453-459
64. Abhilash M, Sauganth Paul M, Varghese MV, et al. Long-term consumption of aspartame and brain antioxidant defense status. Drug Chem Toxicol. 2013;36:135-140
65. Abdel-Salam O, Salem N, El-Shamarka M, et al. Studies on the effects of aspartame on memory and oxidative stress in brain of mice. Eur Rev Med Pharmacol Sci. 2012;16:2092-2101
66. Abdel-Salam OM, Salem NA, Hussein JS. Effect of aspartame on oxidative stress and monoamine neurotransmitter levels in lipopolysaccharide-treated mice. Neurotox Res. 2012;21:245-255
67. Park CH, Choi SH, Piao Y, et al. Glutamate and aspartate impair memory retention and damage hypothalamic neurons in adult mice. Toxicol Lett. 2000;115:117-125
68. Ashok I, Wankhar D, Sheeladevi R, et al. Long-term effect of aspartame on the liver antioxidant status and histopathology in Wistar albino rats. Biomedicine and Preventive Nutrition. 2014;4:299-305
69. Abhilash M, Paul MS, Varghese MV, et al. Effect of long term intake of aspartame on antioxidant defense status in liver. Food Chem Toxicol. 2011;49:1203-1207
70. Choudhary AK, Devi RS. Serum biochemical responses under oxidative stress of aspartame in wistar albino rats. Asian Pac J Trop Dis. 2014;4(suppl 1):S403-S410
71. Arbind K, Sheela Devi R, Sundareswaran L. Role of antioxidant enzymes in oxidative stress and immune response evaluation of aspartame in blood cells of wistar albino rats. Int Food Res J. 2014;21:2263-2272
72. Agamy N. Effects of the natural sweetener (stevia) and the artificial sweetener (aspartame) on some biochemical parameters in normal and alloxan-induced diabetic rats. New Biotechnol. 2009;25:S12. doi:10.1016/j.nbt.2009.06.032
73. Pretorius E, Humphries P. Ultrastructural changes to rabbit fibrin and platelets due to aspartame. Ultrastruct Pathol. 2007;31:77-83
74. Ashok I, Sheeladevi R. Biochemical responses and mitochondrial mediated activation of apoptosis on long-term effect of aspartame in rat brain. Redox Biol. 2014;2:820-831
75. Choudhary AK, Sundareswaran L, Devi RS. Effects of aspartame on the evaluation of electrophysiological responses in Wistar albino rats. J Taibah Univ Sci. 2016;10:505-512
76. Abu-Taweel GM, Zyadah M, Ajarem JS, et al. Cognitive and biochemical effects of monosodium glutamate and aspartame, administered individually and in combination in male albino mice. Neurotoxicol Teratol. 2014;42:60-67
77. Kim J-Y, Seo J, Cho K-H. Aspartame-fed zebrafish exhibit acute deaths with swimming defects and saccharin-fed zebrafish have elevation of cholesteryl ester transfer protein activity in hypercholesterolemia. Food Chem Toxicol. 2011;49:2899-2905
78. Christian B, McConnaughey K, Bethea E, et al. Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+, K+-ATPase in rats. Pharmacol Biochem Behav. 2004;78:121-127
79. Abd El-Samad A. Light and electron microscopic study on the effect of aspartame on the cerebellar cortex of male albino rat. Egypt J Histol. 2010;33:419-430
80. Ashok I, Sheeladevi R. Oxidant stress evoked damage in rat hepatocyte leading to triggered nitric oxide synthase (NOS) levels on long term consumption of aspartame. J Food Drug Anal. 2015;23:679-691
81. Kumar Choudhary A, Selvaraj S, Sheela Devi R. Aspartame induce modification in membrane bound and antioxidant enzymes in liver and kidney of Wistar albino rats. Curr Nutr Food Sci. 2014;10:275-287
82. Iman MM. Effect of aspartame on some oxidative stress parameters in liver and kidney of rats. Afr J Pharm Pharmacol. 2011;5:678-682
83. Martins MRI, Azoubel R. Effects of aspartame on fetal kidney: a morphometric and stereological study. Int J Morphol. 2007;25:689-694
84. Choudhary AK, Sundareswaran L, Devi RS. Aspartame induced cardiac oxidative stress in Wistar albino rats. Nutr Clin Metab. 2016;30:29-37
85. Gudadhe DR, Talhar SS, Bokariya P, et al. Histo-morphometric demonstration of cardiotoxic effects of aspartame on mice. IOSR J Pharm. 2013;3:30-33
86. Choudhary AK, Devi RS. Longer period of oral administration of aspartame on cytokine response in Wistar albino rats. Endocrinol Nutr. 2015;62:114-122
87. Choudhary AK, Rathinasamy SD. Aspartame induces alteration in electrolytes homeostasis of immune organs in wistar albino rats. Biomed Prevent Nutr. 2014;4:181-187
88. Okasha EF. Effect of long term-administration of aspartame on the ultrastructure of sciatic nerve. J Microsc Ultrastruct. 2016;4:175-183
89. Palmnäs MS, Cowan TE, Bomhof MR, et al. Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PLoS One. 2014;9:e109841. doi:10.1371/journal.pone.0109841
90. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514:181-186
91. Mohanty J, Nagababu E, Rifkind JM. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front Physiol. 2014;5:84. doi:10.3389/fphys.2014.00084
92. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84
93. Knight JA. Review: free radicals, antioxidants, and the immune system. Ann Clin Lab Sci. 2000;30:145-158
94. Cemerski S, van Meerwijk JP, Romagnoli P. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur J Immunol. 2003;33:2178-2185
95. + mobilization and aggregation in platelets from type 2 diabetic patients. Biochem Biophys Res Commun. 2005;333:794-802
96. Pacher P, Szabo C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am J Pathol. 2008;173:2-13
97. Sonnen JA, Larson EB, Gray SL, et al. Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol. 2009;65:226-229
98. Haorah J, Ramirez SH, Schall K, et al. Oxidative stress activates protein tyrosine kinase and matrix metalloproteinases leading to blood-brain barrier dysfunction. J Neurochem. 2007;101:566-576
99. Avshalumov MV, Chen BT, Rice ME. Mechanisms underlying H2O2-mediated inhibition of synaptic transmission in rat hippocampal slices. Brain Res. 2000;882:86-94
100. Amor S, Puentes F, Baker D, et al. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154-169
101. Welsh P, Lowe GD, Chalmers J, et al. Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke. 2008;39:2226-2230
102. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, et al. Ischemia/reperfusion injury. J Surg Res. 2002;105:248-258
103. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, et al. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147:153-159
104. Selzner N, Rudiger H, Graf R, et al. Protective strategies against ischemic injury of the liver. Gastroenterology. 2003;125:917-936
105. Wheeler MD. Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health. 2003;27:300-306
106. Koeppen BM. The kidney and acid-base regulation. Adv Physiol Educ. 2009;33:275-281
107. Sureshbabu A, Ryter SW, Choi ME. Oxidative stress and autophagy: crucial modulators of kidney injury. Redox Biol. 2015;4:208-214
108. Barodka VM, Nagababu E, Mohanty JG, et al. New insights provided by a comparison of impaired deformability with erythrocyte oxidative stress for sickle cell disease. Blood Cells Mol Dis. 2014;52:230-235
109. Huertas A, Das SR, Emin M, et al. Erythrocytes induce proinflammatory endothelial activation in hypoxia. Am J Respir Cell Mol Biol. 2013;48:78-86
110. Cemerski S, Cantagrel A, van Meerwijk JP, et al. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J Biol Chem. 2002;277:19585-19593
111. Thorén FB, Betten Å, Romero AI, et al. Cutting edge: antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radicalinduced inactivation and apoptosis. J Immunol. 2007;179:21-25
112. FitzGerald GA. Translational therapeutics at the platelet vascular interface: introduction. Arterioscler Thromb Vasc Biol. 2008;28:S3-S4
113. Mariani E, Polidori M, Cherubini A, et al. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;827:65-75
114. Euston DR, Gruber AJ, McNaughton BL. The role of medial prefrontal cortex in memory and decision making. Neuron. 2012;76:1057-1070
115. Villareal LMA, Cruz RAM, Ples MB, et al. Neurotropic effects of aspartame, stevia and sucralose on memory retention and on the histology of the hippocampus of the ICR mice (Mus musculus). Asian Pac J Trop Biomed. 2016;6:114-118
116. El-Samad AA. Light and electron microscopic study on the effect of aspartame on the cerebellar cortex of male albino rat. Egypt J Histol. 2010;33:419-430
117. Gu Y, Dee C, Shen J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts blood-brain barrier permeability. Front Biosci (Schol Ed). 2010;3:1216-1231
118. Gu Y, Zheng G, Xu M, et al. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem. 2012;120:147-156
119. Muriel P, Gordillo KR. Role of oxidative stress in liver health and disease. Oxid Med Cell Longev. 2016;2016:9037051. doi:10.1155/2016/9037051
120. Contreras-Zentella ML, Hernández-Muñoz R. Is liver enzyme release really associated with cell necrosis induced by oxidant stress? Oxid Med Cell Longev. 2016;2016: 3529149. doi:10.1155/2016/3529149
121. Muriel P. Role of free radicals in liver diseases. Hepatol Int. 2009;3:526-536
122. Kawaratani H, Tsujimoto T, Douhara A, et al. The effect of inflammatory cytokines in alcoholic liver disease. Mediators Inflamm. 2013;2013:495156. doi:10.1155/2013/495156
123. Kim J, Seok YM, Jung K-J, et al. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am J Physiol Renal Physiol. 2009;297:F461-F470
124. Vianna HR, Soares CMBM, Tavares MS, et al. Inflammation in chronic kidney disease: the role of cytokines. J Bras Nefrol. 2011;33:351-364
125. Fowler SP. Low-calorie sweetener use and energy balance: results from experimental studies in animals, and large-scale prospective studies in humans. Physiol Behav. 2016;164(pt B):517-523
126. Shen MJ, Zipes DP. Role of the autonomic nervous system in modulating cardiac arrhythmias. Circul Res. 2014;114:1004-1021
127. von Borell E, Langbein J, Després G, et al. Heart rate variability as a measure of autonomic regulation of cardiac activity for assessing stress and welfare in farm animals-a review. Physiol Behav. 2007;92:293-316
128. Carney RM, Freedland KE, Stein PK, et al. Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res. 2007;62:463-467
129. Victor VM, De La Fuente M. Immune cells redox state from mice with endotoxininduced oxidative stress. Involvement of NF-κB. Free Radic Res. 2003;37:19-27
130. Paiva CN, Bozza MT. Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal. 2014;20:1000-1037
131. Pepino MY, Bourne C. Non-nutritive sweeteners, energy balance, and glucose homeostasis. Curr Opin Clin Nutr Metab Care. 2011;14:391-395
132. Prashant G, Patil RB, Nagaraj T, et al. The antimicrobial activity of the three commercially available intense sweeteners against common periodontal pathogens: an in vitro study. J Contemp Dent Pract. 2012;13:749-752